Elanco动物健康报告Q4收入增加4%, 但错过了EPS的预期, Elanco Animal Health reports Q4 revenue up 4% but misses EPS expectations, causing shares to drop.

Elanco动物健康组织报告,4 Q 2024有机货币常量收入增加了4%,达到10.2亿美元,略低于0.14美元的EPS预期值。 Elanco Animal Health reported a 4% increase in Q4 2024 organic constant currency revenue to $1.02 billion, slightly missing EPS expectations at $0.14. 该公司预计2025年增长4%至6%,2025财政年度EPS指南更新为0.80至0.86美元,2025年Q1 EPS指南更新为0.29至0.34美元。 The company anticipates 4% to 6% growth in 2025, updated FY 2025 EPS guidance to $0.80-$0.86, and Q1 2025 EPS guidance of $0.29-$0.34. 尽管增长强劲,创新强劲,但是由于收入低于预期,年收入下降1.4%,股票下降。 Despite strong growth and innovation, shares dropped due to weaker-than-expected earnings and a 1.4% year-over-year revenue decline.